Craft

Tigermed

Stock Price

¥68.9

2024-10-29

Market Capitalization

¥51.6 B

2024-10-29

Revenue

¥6.7 B

FY, 2025

Tigermed Summary

Company Summary

Overview
Hangzhou Tigermed Consulting (杭州泰格医药科技股份有限公司) is a company that provides clinical research solutions for the biopharmaceutical and medical device industries. Its services include compound screening, medical writing and imaging, data management, statistical analysis, toxicology, bioanalytical, etc.
Type
Public
Status
Active
Founded
2004
HQ
Hangzhou, CN | view all locations
Website
https://www.tigermedgrp.com/en/homepage
Cybersecurity rating
Sectors

Key People

  • Xiaoping Ye, Founder&Chairman&CEO

    LocationsView all

    29 locations detected

    • Hangzhou, Zhe Jiang Sheng HQ

      China

      F 18, Building A - Shengda Science Park, No. 19 Jugong Road, Binjiang District

    • Exton, PA

      United States

      700 Pennsylvania Dr

    • Somerset, NJ

      United States

      100 Franklin Square Dr #102

    • Córdoba, Córdoba

      Argentina

      Calle Humberto Primo 680, Piso 2, Departamento S23

    • Sydney, NSW

      Australia

      Level 35, International Tower one, 100 Barangaroo Avenue

    • São Paulo, SP

      Brazil

      Avenida Paulista Numero 807. Sala 522, Bela Vista

    and 23 others

    Tigermed Financials

    Summary Financials

    Revenue (Q1, 2026)
    ¥1.8B
    Gross profit (Q1, 2026)
    ¥471.3M
    Net income (Q1, 2026)
    ¥330.1M
    Cash (Q1, 2026)
    ¥2.2B
    EBIT (Q1, 2026)
    ¥391.4M
    Enterprise value
    $51.1B

    Footer menu